Health and Quality of Life Outcomes

Table 3 QLQ-C30 questionnaire results

From: Quality of life during chemotherapy, hormonotherapy or antiHER2 therapy of patients with advanced, metastatic breast cancer in clinical practice

QLQ-C30	Before treatment			After treatment
QLQ-C30	Average	Standard deviation	Median	Average	Standard deviation	Median
Performance scales^a
Physical performance	71,77	20,66	72,13	68,27	21,22	69,33
Role fulfilment (work/family)	63,87	29,95	63,67	55,22	29,33	57,25
Emotional functioning	68,44	25,70	68,97	67,66	24,58	68,33
Intellectual performance	72,71	26,18	70,97	70,71	26,25	70,66
Social functioning	73,23	27,94	76,33	74,25	17,99	76,66
Overall quality of life (Qol)	60,92	23,71	58,33	58,20	19,88	58,66
Symptom scales^b
Fatigue	48,33	20,26	44,63	49,11	19,98	50,15
Nausea and vomiting	6,87	8,32	6,67	24,33	10,25	23,99
Pain	29,88	19,33	26,87	28,55	18,41	27,50
Dyspnoea	23,39	13,35	24,10	22,11	15,42	23,10
Sleep disorders	36,33	22,11	36,66	34,99	19,87	33,33
Appetite loss	19,24	12,77	19,01	20,66	11,88	20,30
Constipation	20,77	17,98	23,33	19,54	16,66	18,80
Diarrheal	9,90	11,01	10,40	25,55	18,87	27,05
Financial problems	29,67	29,17	31,33	40,40	30,58	44,20

The significant differences in bold
^a A higher score indicates a better level of functioning and quality of life; min. 0, max. 100
^b A higher value indicates more severe symptoms; min. 0, max. 100

Back to article page

ISSN: 1477-7525

Contact us

Submission enquiries: journalsubmissions@springernature.com